Teaching Inhaler Use With the INCA Device in a Community Pharmacy Setting

Beaumont Hospital

Status

Completed

Conditions

Asthma

Pulmonary Disease, Chronic Obstructive

Treatments

Device: Feedback

Behavioral: Education

Study type

Interventional

Funder types

Other

Identifiers

NCT02203266

RC004

Details and patient eligibility

About

The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to:

Improved compliance with prescribed inhaler use
Improved technique of inhaler use
A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage.
An improvement in patient quality of life scores

Enrollment

152 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Must be 18 years old or above
Capable of understanding and willing to provide voluntary informed consent before any protocol specific procedures are performed
Capable of understanding and complying with the requirements of the protocol, and demonstrating a willingness to attend for all required visits.
Able and willing to take inhaled medication.
Have a valid prescription for use of a Seretide diskus inhaler or already using a Seretide diskus inhaler.
Have a history of regular attendance in the pharmacy in which they are recruited which will be demonstrated by the subject having collected three prescriptions for any medication in that pharmacy in the six months preceeding their recruitment to the study.

Exclusion criteria

Patient expressly reports that their physician has indicated that they will not be continuing to receive Seretide over the next 6 months

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

152 participants in 3 patient groups

Feedback

Experimental group

Description:

Feedback on the patient's own inhaler use, with personalized information on the patients technique and timing of use of the diskus inhaler as recorded on the INCA device will be provided to patients in the feedback group after 1,2 and 6 months.

Treatment:

Device: Feedback

Demonstration

Active Comparator group

Description:

Current best practice - inhaler technique education

Treatment:

Behavioral: Education

Control

No Intervention group

Description:

Usual care in the community pharmacy setting